Petrus Johannes
Petrus Johannes Brember, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20120154086 | Electronic device as well as a base part and an electronic element suitable for use in such an electronic device - An electronic device ( | 06-21-2012 |
Petrus Johannes Buijsman, Hillegom NL
Patent application number | Description | Published |
---|---|---|
20080267705 | Civil Engineering Compartmented Roller - A roller for compacting a subsurface, in particular for road building, comprising a roller body with a central axis. The roller body is made up of a plurality of compartments ( | 10-30-2008 |
Petrus Johannes Devilee, Dortmund DE
Patent application number | Description | Published |
---|---|---|
20150312069 | ELECTRICAL APPARATUS FOR TRANSMITTING ELECTRICAL ENERGY IN A CLOCKED MANNER - The electrical apparatus ( | 10-29-2015 |
Petrus Johannes Geutjes, Nijmegen NL
Patent application number | Description | Published |
---|---|---|
20090274734 | METHOD FOR OBTAINING HOLLOW PARTICLES - Described is a method for obtaining hollow particles, having a particle wall and a particle lumen, the particle having dimensions of between 1 nm and 100 μm, from a mixture comprising a liquid medium comprising at least one colloid or solute, the method comprising freezing said mixture and lyophilising the obtained frozen mixture, characterised in that a volume of at least 0.1 μl of the mixture is subjected to a freezing step comprising: (a) (1) quench freezing the mixture resulting in a quench frozen mixture, and (2) incubating said quench frozen mixture at a temperature above the quench freezing temperature and below the melting point of the liquid medium, orb) (1) reducing the temperature of the mixture at a rate of 1 to 100° C./minute to below the freezing temperature of the mixture and (2) incubating said frozen mixture at a temperature above the temperature of the mixture and below the melting point of the liquid medium. Further, hollow particles obtainable by the said method, compositions comprising said hollow particles and uses thereof are described. | 11-05-2009 |
Petrus Johannes Koot, Koudekerk Aan De Rijn NL
Patent application number | Description | Published |
---|---|---|
20090078533 | APPARATUS FOR PROCESSING ELONGATE PRODUCTS SUCH AS CUCUMBERS - Apparatus for processing generally elongate curved products having two ends and having a longitudinal axis extending in the elongate direction, in particular vegetables or fruit, for instance cucumbers, the processing comprising in succession at least: conveying the products with an endless conveyor in a conveying direction T in a substantially horizontal plane, the products positioned with their longitudinal axis substantially perpendicular to the conveying direction T; orienting these products with an orienting unit, and taking up the oriented products with a take-up unit for a further handling; wherein the orienting unit comprises two supporting points for each product, with at least one supporting point situated at some distance from an end of the product, wherein the orienting unit is configured for orienting during conveying, and wherein the products upon orienting rotate substantially about their longitudinal axis. | 03-26-2009 |
Petrus Johannes Lenting, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20110118188 | FACTOR VIII POLYPEPTIDE HAVING FACTOR VIII:C ACTIVITY - Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same. | 05-19-2011 |
Petrus Johannes Meyer, George ZA
Patent application number | Description | Published |
---|---|---|
20120301422 | ENHANCEMENT OF THE ACTION OF ANTI-INFECTIVE AGENTS AND OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM AGENTS AND TRANSPORTATION OF NUCLEIC ACID SUBSTANCES - The invention provides a method of enhancing the action of a pharmaceutical agent selected from the group consisting of the anti-infective agents, the group comprising of the antimicrobial agents, the anthelmintic agents and the anti-ectoparasitic agents, but excluding coal tar solution and H1-antagonist antihistamines, and from the group consisting of the CPNS agents selected from the group of compounds acting on the central or peripheral nervous system, but excluding coal tar solution and H1-antagonist antihistamines and also excluding anti-inflammatory, analgesic and antipyretic agents and also provides an enhanced method for the administration of a nucleic acid substance to the cells of an animal, a plant or a micro-organism. The method is characterised in that the agent or nucleic acid substance is formulated with an administration medium which comprises a solution of nitrous oxide gas in a pharmaceutically acceptable carrier solvent for the gas and which administration medium includes at least one fatty acid or ester or other suitable derivative thereof selected from the group consisting of oleic acid, linoleic acid, alpha-linolenic acid, gamma-linolenic acid, arachidonic acid, eicosapentaenoic acid [C20:5ω3], decosahexaenoic acid [C22:6ω3], ricinoleic acid and derivatives thereof selected from the group consisting of the C1 to C6 alkyl esters thereof, the glycerol-polyethylene glycol esters thereof and the reaction product of hydrogenated natural oils composed largely of ricinoleic acid based oils, such as castor oil with ethylene oxide. The formulations of such agents or substances form part of the invention | 11-29-2012 |
20130336990 | ENHANCEMENT OF THE ACTION OF ANTI-INFECTIVE AGENTS AND OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM AGENTS AND TRANSPORTATION OF NUCLEIC ACID SUBSTANCES - The invention provides a method of enhancing the action of a pharmaceutical agent selected from the group consisting of the anti-infective agents, the group comprising of the antimicrobial agents, the anthelmintic agents and the anti-ectoparasitic agents, but excluding coal tar solution and H1-antagonist antihistamines, and from the group consisting of the CPNS agents selected from the group of compounds acting on the central or peripheral nervous system, but excluding coal tar solution and H1-antagonist antihistamines and also excluding anti-inflammatory, analgesic and antipyretic agents and also provides an enhanced method for the administration of a nucleic acid substance to the cells of an animal, a plant or a micro-organism. The method is characterised in that the agent or nucleic acid substance is formulated with an administration medium which comprises a solution of nitrous oxide gas in a pharmaceutically acceptable carrier solvent for the gas and which administration medium includes at least one fatty acid or ester or other suitable derivative thereof selected from the group consisting of oleic acid, linoleic acid, alpha-linolenic acid, gamma-linolenic acid, arachidonic acid, eicosapentaenoic acid [C20:5ω3], decosahexaenoic acid [C22:6ω3], ricinoleic acid and derivatives thereof selected from the group consisting of the C1 to C6 alkyl esters thereof, the glycerol-polyethylene glycol esters thereof and the reaction product of hydrogenated natural oils composed largely of ricinoleic acid based oils, such as castor oil with ethylene oxide. The formulations of such agents or substances form part of the invention | 12-19-2013 |
Petrus Johannes Vander Spek, Ge Rotterdam NL
Patent application number | Description | Published |
---|---|---|
20110059089 | Protein Markers for Cardiovascular Events - The present invention relates to a method for predicting the risk of a subject developing a cardiovascular event comprising detecting at least one biomarker in (a sample of) the cardiovascular system from said subject, wherein said biomarker comprises at least one protein selected from the group consisting of Tumor Necrosis Factor Alpha Precursor; Lysosomal-associated Membrane Protein (1); Interleukin-5 Precursor; Interleukin-6 Precursor; C-C Motif Chemokine (2) Precursor; C-C Motif Chemokine (5) Precursor RANTES; Cathepsin L1 Precursor; Adenylate Kinase (1); Leukotriene B4 Receptor (1); Complement Factor D; Secreted Phosphoprotein (1); Small Inducible Cytokine A17 Precursor; C-X-C Motif Chemokine (10) Precursor; Tumor Necrosis Factor Ligand Superfamily Member (11) (RANKL); C-C Motif Chemokine (18) Precursor; 72 kDa Type IVCollagenase Precursor; Neutrophil Collagenase Precursor; fatty acid binding protein (4); calpain (2), (m/II) large subunit; Macrophage Migration Inhibitory Factor; Cathepsin S Precursor; Interleukin (13) Precursor; and soluble ICAM-1. | 03-10-2011 |
Petrus Johannes Van Swaaij, Enschede NL
Patent application number | Description | Published |
---|---|---|
20100052362 | METHOD FOR MUTUALLY ADHERING MOULDED ARTICLES OF VULCANIZED RUBBER - The invention relates to a method for mutually adhering moulded articles of at least partially vulcanized rubber polymers. The method comprises at least the steps of providing a rubber composition which comprises a peroxide with an initiating temperature lower than the vulcanization temperature of at least one of the rubber polymers; arranging an adhesive layer of the rubber composition on the surface of the moulded articles which is to be adhered; bringing the surfaces for adhering together under pressure; and vulcanizing at least the adhesive layer at an increased temperature. | 03-04-2010 |
20150151516 | METHOD FOR MUTUALLY ADHERING MOULDED ARTICLES OF VULCANIZED RUBBER - The invention relates to a method for mutually adhering moulded articles of at least partially vulcanized rubber polymers. The method comprises at least the steps of providing a rubber composition which comprises a peroxide with an initiating temperature lower than the vulcanization temperature of at least one of the rubber polymers; arranging an adhesive layer of the rubber composition on the surface of the moulded articles which is to be adhered; bringing the surfaces for adhering together under pressure; and vulcanizing at least the adhesive layer at an increased temperature. | 06-04-2015 |
Petrus Johannes Withagen, Halsteren NL
Patent application number | Description | Published |
---|---|---|
20140307855 | REAL-TIME FEEDBACK FOR PREVENTING HIGH DOSE C-ARCH GEOMETRY POSITIONS - The present invention relates to an apparatus for aiding operation of an interventional x-ray imager during image acquisition, to a method of aiding operation of an x-ray imager, to an interventional x-ray imager, to a computer program element and to a computer readable medium. The X-ray imager is capable of varying X-ray dosages depending on differences in X-ray attenuation levels across an object of interest to be imaged and is capable of assuming any one of a plurality of imaging geometry positions when acquiring an image. An indication, visual, acoustic or haptic, to the operator of an X-ray imager is provided on the incurred change in X-ray dosage when changing from a current projection view to an updated projection view, provided that a given constant image quality is to be maintained throughout the different views. | 10-16-2014 |